ArticleThoracic cancer2024

Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancer.

Naoko Shigeta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.